Drugs Made In America Acquisition Statistics

NASDAQ: DMAAFinancial ServicesShell CompaniesUSD

10.85+0.02 (+0.18%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Drugs Made In America Acquisition by the numbers

Drugs Made In America Acquisition has a market capitalization of $263.4 million based on 24.28M shares outstanding. Its trailing P/E ratio is 60.3. The stock trades 0.6% above its 50-day average and 2.5% above its 200-day average.

Average daily trading volume is 21.64K shares, or about $234,848 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DMAA valuation vs. peer median

DMAA compared with the median of 8 peer companies
Metric	DMAA	Peer median	Difference
Market cap	$263.40M	$253.23M	+4%
Avg. volume	21.64K	26.28K	-18%

Peer median across 8 companies: NTWO, VLOS, SCII, MTAK, KFIIU, OHAC, IPHX, PNAQ.

Valuation

Market cap: $263.40M
P/E (TTM): 60.28
Forward P/E: —
EPS (TTM): $0.18
Shares outstanding: 24.28M

Price and trading

Previous close: 10.83
Open: 10.85
Day range: 10.85 – 10.85
52-week range: 10.26 – 10.89
50-day moving average: 10.78
200-day moving average: 10.59
Beta: —
Volume: 5.40K
Average volume: 21.64K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: May 20, 2025

Additional statistics

Market Cap: 263.40M
Pe: 60.28
Eps: 0.18
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 10.89
Week52 Low: 10.26
Avg Volume: 21,645.00
Shares Outstanding: 24.28M
Ma50: 10.78
Ma200: 10.59
Earnings Date: May 20, 2025
Pct From52w High: -0.37%
Pct From52w Low: 5.75%